What question did this study set out to answer?

April 15, 2026International Journal of Clinical PharmacyOpen Access

Evaluation of consistency in adverse event reporting between trial registry and publications in COVID-19 pharmacological intervention trials

View Full Paper

Ask AI

Bookmark

Authors

MSM. StrikićCroatian Hydrographic Institute SPShelly Melissa PranićUniversity of Split

Discussion

Member takes

Implication

Evaluation shows high discrepancies in adverse event reporting between trial registries and publications in COVID-19 therapeutics, suggesting important gaps in data accuracy.

Key Points

This research evaluates the consistency of adverse event reporting between trial registries and published results in COVID-19 pharmacological trials.
Analyzed adverse event reporting from trial registries
Compared data with published outcomes
Focused on pharmacological interventions for COVID-19
High discrepancy rate observed between trial registry reports and published results
Inconsistencies could impact patient safety and treatment guidelines
Findings indicate a need for improved transparency in clinical trial reporting

Cite This Study

Strikić et al. (2026) studied this question.

synapsesocial.com/papers/69df2c01e4eeef8a2a6b0f4f https://doi.org/10.1007/s11096-026-02130-2

View Full Paper

Ask AI

Bookmark

Implication

Evaluation shows high discrepancies in adverse event reporting between trial registries and publications in COVID-19 therapeutics, suggesting important gaps in data accuracy.

Evaluation of consistency in adverse event reporting between trial registry and publications in COVID-19 pharmacological intervention trials

Discussion

Member takes

Implication

Key Points

Cite This Study

Evaluation of consistency in adverse event reporting between trial registry and publications in COVID-19 pharmacological intervention trials

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider